Artwork

Sisällön tarjoaa International Anal Neoplasia Society (IANS), Eric Ganz, MD, Mary-Jo Murphy, and RN. International Anal Neoplasia Society (IANS), Eric Ganz, MD, Mary-Jo Murphy, and RN tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Player FM - Podcast-sovellus
Siirry offline-tilaan Player FM avulla!

Dr. Joel Palefsky: The Father of Anal Dysplasia Screening, Treatment, and Research

35:39
 
Jaa
 

Manage episode 407390346 series 3561422
Sisällön tarjoaa International Anal Neoplasia Society (IANS), Eric Ganz, MD, Mary-Jo Murphy, and RN. International Anal Neoplasia Society (IANS), Eric Ganz, MD, Mary-Jo Murphy, and RN tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

Dr. Joel Palefsky discusses his long career and trailblazing research. He discusses the cervical model which informed his research. He talks of the success of his groundbreaking ANCHOR study, a large clinical trial that found, as with the cervix, treating anal precancerous growths greatly reduces the chance of developing cancer.

As his work evolved, Palefsky’s vision expanded. He saw a need to create a way for scientists and clinicians in this young field to interact and collaborate. The Anal Cancer Foundation and the Farrah Fawcett Foundation graciously stepped up to help financially, and IANS was born.

Dr. Palefsky sees ANCHOR as only the beginning of creating innovations in patient care. He expresses hopefulness that in the future the 500,000 specimens collected during the study will help define HPV types and identify which will regress and which remain persistent.

His work was not done for prestige, but his groundbreaking study has brought him that.

Dr. Palefsly ends with a reflection on his life’s work, hopes and dreams.

  continue reading

10 jaksoa

Artwork
iconJaa
 
Manage episode 407390346 series 3561422
Sisällön tarjoaa International Anal Neoplasia Society (IANS), Eric Ganz, MD, Mary-Jo Murphy, and RN. International Anal Neoplasia Society (IANS), Eric Ganz, MD, Mary-Jo Murphy, and RN tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

Dr. Joel Palefsky discusses his long career and trailblazing research. He discusses the cervical model which informed his research. He talks of the success of his groundbreaking ANCHOR study, a large clinical trial that found, as with the cervix, treating anal precancerous growths greatly reduces the chance of developing cancer.

As his work evolved, Palefsky’s vision expanded. He saw a need to create a way for scientists and clinicians in this young field to interact and collaborate. The Anal Cancer Foundation and the Farrah Fawcett Foundation graciously stepped up to help financially, and IANS was born.

Dr. Palefsky sees ANCHOR as only the beginning of creating innovations in patient care. He expresses hopefulness that in the future the 500,000 specimens collected during the study will help define HPV types and identify which will regress and which remain persistent.

His work was not done for prestige, but his groundbreaking study has brought him that.

Dr. Palefsly ends with a reflection on his life’s work, hopes and dreams.

  continue reading

10 jaksoa

Kaikki jaksot

×
 
Loading …

Tervetuloa Player FM:n!

Player FM skannaa verkkoa löytääkseen korkealaatuisia podcasteja, joista voit nauttia juuri nyt. Se on paras podcast-sovellus ja toimii Androidilla, iPhonela, ja verkossa. Rekisteröidy sykronoidaksesi tilaukset laitteiden välillä.

 

Pikakäyttöopas